ARVIGO, MARICA
 Distribuzione geografica
Continente #
EU - Europa 6.691
AS - Asia 653
NA - Nord America 582
SA - Sud America 69
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 9
OC - Oceania 1
Totale 8.073
Nazione #
IT - Italia 6.589
US - Stati Uniti d'America 539
SG - Singapore 254
CN - Cina 165
VN - Vietnam 117
BD - Bangladesh 55
BR - Brasile 47
FR - Francia 44
CA - Canada 19
HK - Hong Kong 19
AR - Argentina 15
DE - Germania 12
FI - Finlandia 10
CH - Svizzera 8
GB - Regno Unito 8
JM - Giamaica 6
JP - Giappone 6
MX - Messico 6
ID - Indonesia 5
IE - Irlanda 5
IQ - Iraq 5
PH - Filippine 4
SA - Arabia Saudita 4
TH - Thailandia 4
ZA - Sudafrica 4
BY - Bielorussia 3
CR - Costa Rica 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
GT - Guatemala 2
IN - India 2
PK - Pakistan 2
UA - Ucraina 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
ES - Italia 1
ET - Etiopia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
NE - Niger 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PL - Polonia 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SI - Slovenia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VI - Stati Uniti Isole Vergini 1
Totale 8.006
Città #
Genova 4.072
Genoa 1.526
Rapallo 526
Vado Ligure 405
San Jose 161
Singapore 108
Ashburn 56
Ho Chi Minh City 46
Lauterbourg 42
Hanoi 26
Beijing 22
Hong Kong 19
New York 15
Santa Clara 13
Frankfurt am Main 12
Council Bluffs 10
Los Angeles 10
Milan 8
Helsinki 7
Zurich 7
Chicago 6
San Francisco 6
Tokyo 6
Atlanta 5
Boardman 5
Bologna 5
Buffalo 5
Dallas 5
Dublin 5
Haiphong 5
Mexico City 5
Orem 5
Philadelphia 5
Bordighera 4
City of London 4
Da Nang 4
Guangzhou 4
Naples 4
Rome 4
São Paulo 4
Toronto 4
Bangkok 3
Buenos Aires 3
Cardiff 3
Charlotte 3
Colorado Springs 3
Kingston 3
Lakeland 3
Lappeenranta 3
Newark 3
Reggio Emilia 3
Taranto 3
Tianjin 3
Turin 3
Westerville 3
Baghdad 2
Biên Hòa 2
Brentwood 2
Carmichael 2
Corryton 2
El Paso 2
Hammond 2
Hewitt 2
Hialeah 2
Houston 2
Imus 2
Jeddah 2
Jinan 2
Johannesburg 2
Lomas de Zamora 2
Madison 2
Mansfield 2
Mesa 2
Modena 2
Montreal 2
Montréal-Nord 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Queens 2
Rio de Janeiro 2
Riyadh 2
San José 2
Secaucus 2
Shanghai 2
Spring Hill 2
Sterling Heights 2
Stockholm 2
Tucson 2
Tulsa 2
Washington 2
Wesley Chapel 2
Windsor 2
Abbeville 1
Abu Dhabi 1
Addis Ababa 1
Aiken 1
Alajuela 1
Albertville 1
Amman 1
Totale 7.316
Nome #
Bone turnover and mineral density in adult thalassemic patients: relationships with growth hormone secretory status and circulating somatomedins 323
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 213
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 213
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 207
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 196
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 194
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 187
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 186
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 186
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 184
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 182
Somatostatin-induced activation and up-regulation of N-methyl-D-aspartate receptor function: mediation through calmodulin-dependent protein kinase II, phospholipase C, protein kinase C, and tyrosine kinase in hippocampal noradrenergic nerve endings. 180
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 180
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 173
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 171
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 170
Canine pancreatic islet cell tumours secreting insulin-like growth factor type 2: A rare entity 168
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 167
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 165
Somatostatin receptor scintigraphy in thoracic diseases 162
Octreotide and pasireotide combination treatment in somatotroph tumor cells: Predominant role of sst2 in mediating ligand effects 162
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 161
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 156
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 153
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 153
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 151
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 149
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 148
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 148
Role of adiponectin and leptin on body development in infants during the first year of life 146
Role of somatostatin analogues in the management of immunolymphoproliferative diseases 140
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 140
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 140
Dopamine receptor expression and function in corticotroph pituitary tumors. 138
In memory of Francesco Maria Minuto. 138
Abstracts of the 6th Annual ENETS Conference, Granada, Spain, March 5–7, 2009 136
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 135
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 134
Novel chimeric somatostatin analogs: facts and perspectives 132
The IGF system and bone 127
Decreased acid-labile subunit (ALS) levels by endotoxin in vivo and by interleukin-1beta in vitro 125
Efficacy of a slow-release formulation of lanreotide (Autogel) 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study. 124
IGF-I production by adult rat hepatocytes is stimulated by transforming growth factor alfa and trasforming growth factor beta1 122
Digital quantification of somatostatin receptor subtypes 2 and 5 in growth hormone–secreting pituitary tumors 117
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 112
null 110
Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism 108
Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression. 104
Rationale for treating cancer with somatostatin analogs. 102
Corrigendum to "Regulation of prostate cancer cell proliferation by somatostatin receptor activation" [Mol. Cell. Endocrinol. 315 (1-2) (2010) 254-262] 77
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 71
The role of somatostatin analogs in the management of immunoproliferative disease 66
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids 64
Somatostatin receptor expression and patients' response to targeted medical treatment in pituitary tumors: evidences and controversies. 53
Somatostatin receptor pathophysiology in the neuroendocrine system 24
Totale 8.073
Categoria #
all - tutte 24.753
article - articoli 24.446
book - libri 0
conference - conferenze 307
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.506


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022667 14 44 65 91 18 40 32 148 34 58 28 95
2022/2023622 58 62 7 70 79 101 0 50 96 5 90 4
2023/2024307 18 38 4 49 18 48 23 12 13 5 38 41
2024/20251.055 36 75 30 55 136 99 118 180 34 36 108 148
2025/20261.789 236 47 94 160 237 143 263 89 143 151 106 120
2026/2027179 179 0 0 0 0 0 0 0 0 0 0 0
Totale 8.073